Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 8 Neoplasms 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Brain Neoplasms 3 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Ketogen-based Therapeutic Diet 1 Intermittent Fasting 1 Head and Neck Neoplasms 1 Growth Hormone-Secreting Pituitary Adenoma 1 Glioma 1 Fatty Liver 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 31 Pemetrexed 28 Radiotherapy 22 Bevacizumab 21 Cisplatin 20 Gemcitabine 18 Paclitaxel 17 Erlotinib Hydrochloride 15 Docetaxel 12 Gefitinib 8 Nivolumab 6 Mastectomy, Segmental 6 Magnetic Resonance Spectroscopy 6 pembrolizumab 5 aflutinib 5 Radiosurgery 5 tislelizumab 4 Vinorelbine 4 Surgical Procedures, Operative 4 Specimen Handling 4 Sorafenib 4 Platinum 4 Metformin 4 Biopsy 4 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 4 sargramostim 3 apatinib 3 Taxes 3 Cetuximab 3 Anterior Temporal Lobectomy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma of Lung × Diet, Ketogenic × Clear all

NCT07479095 2026-03-20

KETO-FDG Lung

Fondazione del Piemonte per l'Oncologia

Phase NA Recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡